Literature DB >> 15459512

Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain.

Y Aladro1, M J Alemany, M C Pérez-Vieitez, R Amela, M Conde, M P Reyes, F Alamo, A Angel-Moreno.   

Abstract

OBJECTIVES: To determine the prevalence and incidence of multiple sclerosis (MS) in the city of Las Palmas (Canary Islands, Spain), geographically belonging to north-western Africa, but with European ancestry.
METHODS: This population-based survey was conducted for a period of 5 years (1998-2002) in a Sanitary District of Las Palmas city (28 degrees 20' N), with a population of 82,623 inhabitants. Multiple sources were periodically investigated for case ascertainment. Patients with definite and probable MS were included.
RESULTS: Sixty-four patients with MS were identified on prevalence day, December 31, 2002. According to Poser's criteria the crude prevalence rate was 77.5 per 100,000 (95% CI: 59.7-98.9). This rate decreased to 73.8 (95% CI: 56.5-94.8) according to McDonald's criteria. Age-adjusted rates for the world and European standard populations were 61.6 (95% CI: 47.1-78.9) and 70.6 (95% CI: 55-89), respectively. Prevalence was higher for women aged 25-44 years. In 17 patients onset of MS occurred within the study period. Average annual incidence was 4.1 per 100,000 (95% CI: 2.4-6.6).
CONCLUSIONS: The prevalence and incidence rates in Las Palmas city are close to those reported from Continental Spain and other countries of southern Europe with similar social and ethnic background. These results highlight the role of racial-ethnic factors in the genesis of MS.

Entities:  

Mesh:

Year:  2004        PMID: 15459512     DOI: 10.1159/000081052

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

Review 1.  Temporal trends in the incidence of multiple sclerosis: a systematic review.

Authors:  Alvaro Alonso; Miguel A Hernán
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

2.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 3.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

4.  Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.

Authors:  Rainel Sánchez-de la Rosa; Laura García-Bujalance; José Meca-Lallana
Journal:  Health Econ Rev       Date:  2015-10-16

5.  Cognitive status in patients with multiple sclerosis in Lanzarote.

Authors:  María Yaiza Pérez-Martín; Pablo Eguia-Del Río; Montserrat González-Platas; Alejandro Jiménez-Sosa
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-30       Impact factor: 2.570

6.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

7.  Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.

Authors:  Stéphanie Foulon; Géric Maura; Marie Dalichampt; François Alla; Marc Debouverie; Thibault Moreau; Alain Weill
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

8.  Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain.

Authors:  Silvia Pérez-Pérez; Pablo Eguia Del Rio; María Inmaculada Domínguez-Mozo; María Ángel García-Martínez; María Francisca Zapata-Ramos; Maria Jose Torrejon; Rafael Arroyo; Roberto Alvarez-Lafuente
Journal:  PeerJ       Date:  2019-12-18       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.